Signal Transduction and G Protein Mechanisms in Cardiovascular Physiology

Fundamental Principles of Signal Transduction and G Proteins

  • Signal transduction is the biological process through which cells detect and respond to external stimuli, converting these external cues into specific intracellular signals.

  • G proteins (Guanine nucleotide-binding proteins) represent a major family of proteins that serve as essential intermediaries in signal transduction. They bridge the gap between cell surface receptors and various intracellular signaling pathways.

  • G-Protein Coupled Receptors (GPCRs) are the primary type of receptor involved in the second messenger system.

  • The molecular mechanism of GPCR activation involves several steps:

    • A ligand (such as a hormone or catecholamine) binds to the extracellular portion of the GPCR.

    • This binding induces a conformational change in the three subunits of the associated G protein.

    • The activated Alpha (α\alpha) subunit dissociates from the Beta (β\beta) and Gamma (γ\gamma) subunits to initiate downstream effects.

Second Messenger Signaling Pathways

  • The specific cellular response is determined by the type of G protein alpha subunit that is activated. These are categorized into distinct pathways:

  • The Gs Pathway (Stimulatory):

    • The activated Alpha subunit stimulates the enzyme Adenylyl Cyclase (ACAC).

    • Adenylyl Cyclase converts Adenosine Triphosphate (ATPATP) into Cyclic Adenosine Monophosphate (cAMPcAMP).

    • cAMPcAMP acts as a second messenger to activate Protein Kinase A (PKAPKA).

  • The Gi Pathway (Inhibitory):

    • The activated Alpha subunit inhibits the enzyme Adenylyl Cyclase (ACAC).

    • This inhibition prevents the conversion of ATPATP to cAMPcAMP, thereby preventing the activation of PKAPKA.

  • The Gq Pathway:

    • The activated Alpha subunit stimulates the enzyme Phospholipase C (PLCPLC).

    • PLCPLC converts Phosphatidylinositol 4,5-bisphosphate (PIP2PIP_2) into two key molecules: Inositol 1,4,5-trisphosphate (IP3IP_3) and Diacylglycerol (DAGDAG).

    • IP3IP_3 triggers the release of Calcium (Ca2+Ca^{2+}) from the Sarcoplasmic Reticulum (SRSR).

    • DAGDAG and the increased calcium levels lead to the activation of Protein Kinase C (PKCPKC).

Cardiovascular Signal Transduction: The Heart

  • In cardiac cells, G proteins regulate heart rate and contractility through GPCRs.

  • Receptor Dynamics: The heart contains Beta-1 (β1\beta_1) adrenergic receptors. These receptors bind to hormones, specifically the catecholamines Adrenaline and Noradrenaline.

  • Intracellular Cascade: Activation of These receptors triggers the Gs pathway, leading to increased production of cAMPcAMP and subsequent activation of PKAPKA.

  • Phosphorylation Effects: PKAPKA phosphorylates various target proteins within the cardiac tissue, resulting in three primary physiological outcomes:

    • Positive Inotropic Effect: An increase in the force of myocardial contractility.

    • Positive Chronotropic Effect: An increase in the heart rate.

    • Positive Dromotropic Effect: An increase in the rate of electrical conduction through the Atrioventricular (AVAV) node.

Cardiovascular Signal Transduction: The Arteries

  • In the vasculature, G proteins regulate vascular tone, arterial diameter, and blood pressure.

  • Vascular Smooth Muscle Contraction: GPCRs in vascular smooth muscle cells bind to hormones such as Angiotensin II and Endothelin-1.

  • Calcium - Mediated Vasoconstriction: This activation typically involves the production of Inositol trisphosphate (IP3IP_3), which releases Ca2+Ca^{2+} from intracellular stores. The rise in intracellular calcium leads to the contraction of smooth muscle cells.

  • Alpha-1 (α1\alpha_1) Adrenergic Receptors:

    • Located on smooth muscle cells in blood vessels.

    • Activated by Adrenaline and Noradrenaline released by the sympathetic nervous system.

    • Signaling through G proteins increases intracellular calcium, causing vasoconstriction.

  • Vasopressin Receptors:

    • Vasopressin (Antidiuretic Hormone) is a peptide hormone released by the pituitary gland in response to low blood volume or low blood pressure.

    • It acts on vasopressin receptors (V1V_1) in blood vessels to cause vasoconstriction via G protein signaling and increased intracellular calcium.

  • Physiological Impact: Vasoconstriction narrows the arterial diameter, which increases vascular resistance and consequently raises blood pressure.

Vasodilation and the Nitric Oxide Pathway

  • A separate mechanism for signal transduction in vascular smooth muscle involves Nitric Oxide (NONO) and cyclic Guanosine Monophosphate (cGMPcGMP).

  • Mechanism of Action:

    • Endothelial cells produce NONO.

    • NONO activates the enzyme Guanylyl Cyclase (GCGC) within the smooth muscle cells.

    • Guanylyl Cyclase produces cGMPcGMP, which then activates Protein Kinase G.

    • This sequence results in vasodilation, rather than contraction.

Physiological and Pharmacological Applications

  • Endocrinology and GPCRs: Various hormones utilize G protein pathways, including:

    • Vasopressin (utilizing both V1V_1 and V2V_2 receptors).

    • Glucagon.

    • Angiotensin II.

  • Beta-Blockers: These drugs block GPCR-mediated activation of G proteins in the heart. By preventing the effects of adrenaline and noradrenaline, they decrease heart rate and contractility, making them effective for treating hypertension and heart failure.

  • Calcium Channel Blockers: These drugs target the signaling cascade in the arteries by blocking the influx of extracellular calcium into smooth muscle cells. This results in smooth muscle relaxation, increased arterial diameter, and decreased vascular resistance and blood pressure.

  • Vasopressors:

    • This class of drugs increases blood pressure by inducing vasoconstriction.

    • Phenylephrine: Acts specifically as an agonist for α1\alpha_1 adrenergic receptors.

    • Vasopressin and Terlipressin: Synthetic analogs or naturally occurring hormones that target vasopressin receptors to cause vasoconstriction.

Chemical and Biological Terminology

  • ACAC (Adenylyl cyclase): An enzyme that catalyzes the production of cAMPcAMP.

  • cAMPcAMP (Cyclic adenosine monophosphate): A second messenger molecule used for intracellular signal transduction.

  • ATPATP (Adenosine triphosphate): An organic compound that provides energy for many cellular processes.

  • PKAPKA (Protein Kinase A): An enzyme that phosphorylates target proteins in response to cAMPcAMP levels.

  • PKCPKC (Protein Kinase C): An enzyme involved in signaling pathways that regulate diverse cellular functions.

  • GDPGDP (Guanosine diphosphate): A nucleoside phosphate resulting from the dephosphorylation of GTPGTP.

  • GTPGTP (Guanosine-5'-triphosphate): A purine nucleoside triphosphate required for the activation of G proteins.

  • PLCPLC (Phospholipase C): An enzyme that cleaves PIP2PIP_2 into IP3IP_3 and DAGDAG.

  • PIP2PIP_2 (Phosphatidylinositol 4,5-bisphosphate): A phospholipid component of the cell membrane.

  • IP3IP_3 (Inositol 1,4,5-trisphosphate): A signaling molecule that facilitates the release of calcium from the sarcoplasmic reticulum.

  • DAGDAG (Diacylglycerol): A lipid second messenger that activates Protein Kinase C.

  • SRSR (Sarcoplasmic reticulum): A specialized form of endoplasmic reticulum in muscle cells used for storing and releasing calcium (Ca2+Ca^{2+}).